K Nishimaru

1.4k total citations
24 papers, 1.0k citations indexed

About

K Nishimaru is a scholar working on Pulmonary and Respiratory Medicine, Epidemiology and Neurology. According to data from OpenAlex, K Nishimaru has authored 24 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pulmonary and Respiratory Medicine, 9 papers in Epidemiology and 8 papers in Neurology. Recurrent topics in K Nishimaru's work include Cerebrovascular and Carotid Artery Diseases (8 papers), Acute Ischemic Stroke Management (8 papers) and Antiplatelet Therapy and Cardiovascular Diseases (7 papers). K Nishimaru is often cited by papers focused on Cerebrovascular and Carotid Artery Diseases (8 papers), Acute Ischemic Stroke Management (8 papers) and Antiplatelet Therapy and Cardiovascular Diseases (7 papers). K Nishimaru collaborates with scholars based in Japan, United States and United Kingdom. K Nishimaru's co-authors include Yukito Shinohara, Takenori Yamaguchi, Yasuo Ohashi, Shinichiro Uchiyama, Tohru Sawada, Akiro Terashi, Shunnosuke Handa, Fumio Gotoh, Hideo Tohgi and E Otomo and has published in prestigious journals such as Stroke, The Lancet Neurology and Journal of Clinical Epidemiology.

In The Last Decade

K Nishimaru

22 papers receiving 996 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
K Nishimaru Japan 12 604 494 358 194 140 24 1.0k
M Haguenau France 12 344 0.6× 354 0.7× 284 0.8× 329 1.7× 127 0.9× 51 1.0k
Aída Lago Spain 15 299 0.5× 361 0.7× 297 0.8× 260 1.3× 90 0.6× 50 1.0k
K. R. Lees United Kingdom 19 527 0.9× 709 1.4× 979 2.7× 488 2.5× 149 1.1× 32 1.6k
Huaguang Zheng China 19 300 0.5× 865 1.8× 319 0.9× 206 1.1× 92 0.7× 50 1.2k
Yoshiyuki Wakugawa Japan 13 268 0.4× 365 0.7× 202 0.6× 161 0.8× 115 0.8× 38 899
Shigetaka Furukado Japan 16 266 0.4× 330 0.7× 268 0.7× 157 0.8× 72 0.5× 24 836
Jordi A. Matías‐Guiu Spain 10 1.2k 2.1× 829 1.7× 573 1.6× 269 1.4× 340 2.4× 23 1.8k
Per-Gunnar Wiklund Sweden 15 258 0.4× 427 0.9× 97 0.3× 203 1.0× 77 0.6× 19 830
Xingquan Zhao China 17 183 0.3× 427 0.9× 187 0.5× 198 1.0× 91 0.7× 43 766
Sang Joon An South Korea 14 163 0.3× 457 0.9× 135 0.4× 559 2.9× 86 0.6× 36 991

Countries citing papers authored by K Nishimaru

Since Specialization
Citations

This map shows the geographic impact of K Nishimaru's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K Nishimaru with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K Nishimaru more than expected).

Fields of papers citing papers by K Nishimaru

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K Nishimaru. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K Nishimaru. The network helps show where K Nishimaru may publish in the future.

Co-authorship network of co-authors of K Nishimaru

This figure shows the co-authorship network connecting the top 25 collaborators of K Nishimaru. A scholar is included among the top collaborators of K Nishimaru based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K Nishimaru. K Nishimaru is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Uchiyama, Shinichiro, Yukito Shinohara, Yasuo Katayama, et al.. (2014). Benefit of Cilostazol in Patients with High Risk of Bleeding: Subanalysis of Cilostazol Stroke Prevention Study 2. Cerebrovascular Diseases. 37(4). 296–303. 39 indexed citations
2.
Shinohara, Yukito, Yasuo Katayama, Shinichiro Uchiyama, et al.. (2010). Cilostazol for prevention of secondary stroke (CSPS 2): an aspirin-controlled, double-blind, randomised non-inferiority trial. The Lancet Neurology. 9(10). 959–968. 356 indexed citations
3.
Shinohara, Yukito & K Nishimaru. (2009). Sarpogrelate Versus Aspirin in Secondary Prevention of Cerebral Infarction: Differential Efficacy in Diabetes?. Stroke. 40(8). 2862–2865. 9 indexed citations
4.
Shinohara, Yukito, Fumio Gotoh, Hideo Tohgi, et al.. (2008). Antiplatelet Cilostazol Is Beneficial in Diabetic and/or Hypertensive Ischemic Stroke Patients. Cerebrovascular Diseases. 26(1). 63–70. 44 indexed citations
5.
Uchiyama, Shinichiro, Yukio Ozaki, Kaneo Satoh, Kazuoki Kondo, & K Nishimaru. (2007). Effect of Sarpogrelate, a 5-HT<sub>2A</sub> Antagonist, on Platelet Aggregation in Patients with Ischemic Stroke: Clinical-Pharmacological Dose-Response Study. Cerebrovascular Diseases. 24(2-3). 264–270. 38 indexed citations
6.
Ishida, Koji, et al.. (2001). Effect of ethanol on hemorheology in patients with ischemic cerebrovascular disease and elderly healthy men.. PubMed. 25(3-4). 135–44. 11 indexed citations
7.
Gotoh, Fumio, Hideo Tohgi, Shunsaku Hirai, et al.. (2000). Cilostazol stroke prevention study: A placebo-controlled double-blind trial for secondary prevention of cerebral infarction. Journal of Stroke and Cerebrovascular Diseases. 9(4). 147–157. 252 indexed citations
8.
Kamei, Hiroyuki, et al.. (1998). Significance of Pontine High Signal Intensity Lesions on Magnetic Resonance Imaging in Patients with Cerebral Infarction.. Nippon Ronen Igakkai Zasshi Japanese Journal of Geriatrics. 35(3). 208–213. 2 indexed citations
9.
Abe, Hirofumi, et al.. (1993). An autopsy case of intracranial idiopathic vertebral artery dissecting aneurysm with serial MRI study.. Nosotchu. 15(2). 144–150. 1 indexed citations
10.
Shijo, Hiroshi, Haruka Sasaki, K Nishimaru, & Makoto Okumura. (1992). Recurrent Intracranial Hemorrhagic Episodes in Hepatopulmonary Syndrome.. Internal Medicine. 31(6). 786–790. 13 indexed citations
11.
Whisnant, Jack P., L. Joseph Melton, Patricia H. Davis, et al.. (1990). Comparison of case ascertainment by medical record linkage and cohort follow-up to determine incidence rates for transient ischemic attacks and stroke. Journal of Clinical Epidemiology. 43(8). 791–797. 47 indexed citations
12.
Keith, D.S., Stephen Phillips, Jack P. Whisnant, K Nishimaru, & W. Michael O’Fallon. (1987). Heparin Therapy for Recent Transient Focal Cerebral Ischemia. Mayo Clinic Proceedings. 62(12). 1101–1106. 22 indexed citations
13.
Ueki, Hiroaki & K Nishimaru. (1985). [Pure sensory stroke due to midbrain hemorrhage--case report].. PubMed. 37(2). 169–72. 4 indexed citations
14.
15.
Nishimaru, K, et al.. (1979). [Long-term prognosis of cerebral infarction--influence of arterial stenotic lesion for survival (author's transl)].. PubMed. 31(11). 1111–6. 2 indexed citations
16.
Fujishima, M, K Nishimaru, & T Omae. (1977). Long-term prognosis for cerebral infarction in relation to brain circulation--a 7-year follow up study.. Stroke. 8(6). 680–683. 7 indexed citations
17.
Nishimaru, K. (1972). [History of angiology].. PubMed. 34(8). 630–9.
18.
Nishimaru, K, Teruo Omae, & S Katsuki. (1971). A Study on Natural History of Transient Cerebral Ischemic Attacks. Nippon Ronen Igakkai Zasshi Japanese Journal of Geriatrics. 8(6). 293–296. 1 indexed citations
19.
Omae, Teruo, S Katsuki, K Nishimaru, et al.. (1969). Clinical features of cerebral infarction in the Japanese. Journal of Chronic Diseases. 21(8). 585–606. 2 indexed citations
20.
Nishimaru, K. (1963). [ARTERIAL ANASTOMOSES IN THE DOG BRAIN].. PubMed. 54. 988–1006. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M Haguenau Breakdown of academic impact, for papers by Aída Lago Breakdown of academic impact, for papers by K. R. Lees Breakdown of academic impact, for papers by Huaguang Zheng Breakdown of academic impact, for papers by Yoshiyuki Wakugawa Breakdown of academic impact, for papers by Shigetaka Furukado Breakdown of academic impact, for papers by Jordi A. Matías‐Guiu Breakdown of academic impact, for papers by Per-Gunnar Wiklund Breakdown of academic impact, for papers by Xingquan Zhao Breakdown of academic impact, for papers by Sang Joon An
Rankless by CCL
2026